SEC Form 4 · accession 0001209191-15-087457
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R. La Neve
Officer — CEO and President · Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 31, 2015 · 11:02 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.59 | Dec 28, 2015 | A | 2,081,191 | A | — | Dec 27, 2025 | Common Stock | 2,081,191 | 2,081,191 | D |
Explanation of responses
- F11/3 of the shares subject to the option shall vest and become exercisable on each of August 17, 2016, August 17, 2017 and August 17, 2018, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2015 Equity Incentive Plan) on each such vesting date.